Institute of Primary Care, University of Zurich & University Hospital Zurich, Zurich, Switzerland.
J Gen Intern Med. 2023 Feb;38(3):610-618. doi: 10.1007/s11606-022-07728-6. Epub 2022 Aug 31.
Medication safety in patients with polypharmacy at transitions of care is a focus of the current Third WHO Global Patient Safety Challenge. Medication review and communication between health care professionals are key targets to reduce medication-related harm.
To study whether a hospital discharge intervention combining medication review with enhanced information transfer between hospital and primary care physicians can delay hospital readmission and impact health care utilization or other health-related outcomes of older inpatients with polypharmacy.
Cluster-randomized controlled trial in 21 Swiss hospitals between January 2019 and September 2020, with 6 months follow-up.
Sixty-eight senior physicians and their blinded junior physicians included 609 patients ≥ 60 years taking ≥ 5 drugs.
Participating hospitals were randomized to either integrate a checklist-guided medication review and communication stimulus into their discharge processes, or follow usual discharge routines.
Primary outcome was time-to-first-readmission to any hospital within 6 months, analyzed using a shared frailty model. Secondary outcomes covered readmission rates, emergency department visits, other medical consultations, mortality, drug numbers, proportions of patients with potentially inappropriate medication, and the patients' quality of life.
At admission, 609 patients (mean age 77.5 (SD 8.6) years, 49.4% female) took a mean of 9.6 (4.2) drugs per patient. Time-to-first-readmission did not differ significantly between study arms (adjusted hazard ratio 1.14 (intervention vs. control arm), 95% CI [0.75-1.71], p = 0.54), nor did the 30-day hospital readmission rates (6.7% [3.3-10.1%] vs. 7.0% [3.6-10.3%]). Overall, there were no clinically relevant differences between study arms at 1, 3, and 6 months after discharge.
The combination of a structured medication review with enhanced information transfer neither delayed hospital readmission nor improved other health-related outcomes of older inpatients with polypharmacy. Our results may help researchers in balancing practicality versus stringency of similar hospital discharge interventions.
ISRCTN18427377, https://doi.org/10.1186/ISRCTN18427377.
在医疗保健过渡时期,接受多种药物治疗的患者的用药安全是当前第三次世界卫生组织全球患者安全挑战的重点。药物审查和卫生保健专业人员之间的信息交流是减少与药物相关的伤害的关键目标。
研究在医院出院干预措施中结合药物审查以及增强医院与初级保健医生之间的信息传递,是否可以延迟医院再入院,并影响老年接受多种药物治疗的住院患者的医疗保健利用或其他与健康相关的结果。
2019 年 1 月至 2020 年 9 月期间,在瑞士的 21 家医院进行了群组随机对照试验,随访 6 个月。
68 位资深医生及其盲法初级医生纳入了 609 位年龄≥60 岁、服用≥5 种药物的患者。
参与的医院被随机分配到将清单指导的药物审查和沟通刺激纳入其出院流程中,或遵循常规出院流程。
主要结局是 6 个月内首次再入院至任何医院的时间,使用共享脆弱性模型进行分析。次要结局包括再入院率、急诊就诊、其他医疗咨询、死亡率、药物数量、潜在不适当药物患者的比例以及患者的生活质量。
入院时,609 位患者(平均年龄 77.5(8.6)岁,49.4%为女性)每人平均服用 9.6(4.2)种药物。研究组之间的首次再入院时间没有显著差异(调整后的危险比 1.14(干预组与对照组),95%CI [0.75-1.71],p=0.54),30 天内的医院再入院率也没有差异(6.7% [3.3-10.1%] vs. 7.0% [3.6-10.3%])。出院后 1、3 和 6 个月,总体而言,两组之间没有明显的临床相关差异。
结构化药物审查与增强信息传递相结合,既没有延迟医院再入院,也没有改善老年接受多种药物治疗的住院患者的其他与健康相关的结果。我们的结果可能有助于研究人员在平衡类似医院出院干预措施的实用性与严格性。
ISRCTN18427377,https://doi.org/10.1186/ISRCTN18427377。